The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

Macular telangiectasia, sometimes referred to as idiopathic juxtafoveal macular telangiectasia, is a disease that affects the part of the eye called the macula, causing degradation or loss of central ...

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, W. Lloyd Clark, MD, discusses positive results from three clinical trials investigating NT-501 for macular telangiectasia type 2.

Long-term safety and efficacy of revakinagene taroretcel (NT-501) ciliary neurotrophic factor implant for macular telangiectasia type 2. Presented at: Retina 2025; Jan. 18-24, 2025; Koloa ...

A total of 92.3% (12/13) of the retinal cysts were located in the inferotemporal quadrant. Fluorescein angiography demonstrated telangiectasia surrounding and/or at the edge of the retinal cyst.

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

The retina is a layered structure that lines the inner surface of the eye. It consists of layers of neurons: light-sensitive photoreceptor cells, bipolar cells, horizontal cells, amacrine cells ...

Meet our experts who are among the world's leaders in treating retina-related disorders and conditions, such as macular degeneration, diabetic retinopathy, retinal detachment, vein occlusion and ...